Heart Failure

View the latest content related to this topic

News Conference News AHA 2025

POLY-HF: Polypill Pays Dividends in Patients With HFrEF

The combination therapy improved LVEF, quality of life, clinical outcomes, and more, but implementation questions remain.

Todd Neale

November 14, 2025

Slides

See all

Presentation ESC 2025

DAPA ACT HF – TIMI 68: Dapagliflozin in Patients Hospitalized for Heart Failure

Presenter: David D. Berg

August 30, 2025

Presentation ESC 2025

Mavacamten in Symptomatic Nonobstructive Cardiomyopathy: Primary results of the ODYSSEY-HCM Trial

Presenter: Milind Y Desai

August 30, 2025

Presentation ESC 2025

Vericiguat in ambulatory patients with chronic heart failure with reduced ejection fraction: Results of the VICTOR trial

Presenter: Faiez Zannad

August 30, 2025

Presentation ESC 2025

Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: REBOOT

Presenter: Borja Ibanez

August 30, 2025

Presentation TCT India 2025

Introduction to MyClip: Transcatheter Edge to Edge Repair System

Presenter: Anil Yadav & Viveka Kumar

July 27, 2025

News

See all

News Daily News

Rising HF Burden in the US Potentially Related to Changes in Cardiometabolic Factors

By Yael L. Maxwell

December 02, 2025

News Opinion CV Team Dispatch

November 2025 Dispatch for the CV Team

By L.A. McKeown

November 24, 2025

News Conference News AHA 2025

POLY-HF: Polypill Pays Dividends in Patients With HFrEF

By Todd Neale

November 14, 2025

News Daily News

Déjà Vu All Over Again? Results of Intracoronary Stem Cell Study Questioned

By Yael L. Maxwell

November 13, 2025

News Conference News AHA 2025

AI-Powered Digital Stethoscope Detects Low EF in Patients With HF Symptoms

By Todd Neale

November 10, 2025

ACC 2025

March 29

March 31, 2025

CTO 2025

February 28

March 01, 2025

THT 2025

February 11

February 13, 2025

Videos on This Topic

See all

Advertisement

Heart Failure

POLY-HF: Polypill Pays Dividends in Patients With HFrEF

Slides

DAPA ACT HF – TIMI 68: Dapagliflozin in Patients Hospitalized for Heart Failure

Mavacamten in Symptomatic Nonobstructive Cardiomyopathy: Primary results of the ODYSSEY-HCM Trial

Vericiguat in ambulatory patients with chronic heart failure with reduced ejection fraction: Results of the VICTOR trial

Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: REBOOT

Introduction to MyClip: Transcatheter Edge to Edge Repair System

News

Rising HF Burden in the US Potentially Related to Changes in Cardiometabolic Factors

November 2025 Dispatch for the CV Team

POLY-HF: Polypill Pays Dividends in Patients With HFrEF

Déjà Vu All Over Again? Results of Intracoronary Stem Cell Study Questioned

AI-Powered Digital Stethoscope Detects Low EF in Patients With HF Symptoms

More on This Topic

Conference Coverage

ACC 2025

CTO 2025

THT 2025

Videos on This Topic

Advertisement

Heart Failure

Slides

News

More on This Topic

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content